Lead exposure and rate of change in cognitive function in older women

Environmental Research

Volumn 129, Issue , 2014, Pages 69-75

  Power, Melinda C ^a   Korrick, Susan ^a,b   Tchetgen Tchetgen, Eric J ^a   Nie, Linda H ^c   Grodstein, Francine ^a,b   Hu, Howard ^d   Weuve, Jennifer ^a,e   Schwartz, Joel ^a   Weisskopf, Marc G ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c PURDUE UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cognition; Cognitive decline; Cohort; Epidemiology; Lead

Indexed keywords

BIOLOGICAL MARKER; LEAD;

ANNUAL VARIATION; BIOMARKER; COGNITION; HEALTH IMPACT; HEALTH MONITORING; HISTORICAL RECORD; LEAD; POLLUTION EFFECT; WOMENS HEALTH;

AGED; ARTICLE; ATTENTION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; EXECUTIVE FUNCTION; EXPOSURE; FEMALE; HUMAN; LEAD BLOOD LEVEL; LEARNING; MAJOR CLINICAL STUDY; MEMORY; PATELLA; PERFORMANCE; PRIORITY JOURNAL; TELEPHONE INTERVIEW; TIBIA; UNITED STATES;

BOSTON; MASSACHUSETTS; UNITED STATES;

COGNITION; COGNITIVE DECLINE; COHORT; EPIDEMIOLOGY; LEAD;

AGED; BONE DENSITY; COGNITION; COGNITION DISORDERS; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; LEAD; LINEAR MODELS; MASSACHUSETTS; NEUROPSYCHOLOGICAL TESTS; TIBIA;

EID: 84893173713     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2013.12.010     Document Type: Article

References (50)

1. 2+ promotes lipid oxidation and alterations in membrane physical properties. Toxicology 1999, 132:19-32.
2. Ahamed M., Siddiqui M.K. Low level lead exposure and oxidative stress: current opinions. Clin. Chim. Acta 2007, 383:57-64.
3. Bandeen-Roche K., et al. Cumulative lead dose and cognitive function in older adults. Epidemiology 2009, 20:831-839.
4. Bassuk S.S., et al. Cognitive impairment and mortality in the community-dwelling elderly. Am. J. Epidemiol. 2000, 151:676-688.
5. Bennett D.A., et al. Natural history of mild cognitive impairment in older persons. Neurology 2002, 59(2):198-205.
6. Braga M.F., et al. Nanomolar concentrations of lead inhibit glutamatergic and GABAergic transmission in hippocampal neurons. Brain. Res. 1999, 826:22-34.
7. Brandt J., et al. The Telephone Interview for Cognitive Status. Neuropsychiatry Neuropsychol. Behav. Neurol. 1988, 1(2):111-117.
8. Colditz G.A., et al. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J. Womens Health 1997, 6:49-62.
9. Gao S., et al. Trace element levels and cognitive function in rural elderly Chinese. J. Gerontol A Biol. Sci. Med. Sci. 2008, 63:635-641.
10. Gaugler J.E., et al. Predicting nursing home admission in the U.S.: a meta-analysis. BMC Geriatr. 2007, 7:13.
11. Hu H., et al. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ. Health Perspect. 1998, 106:1-8.
12. Jackson L.W., et al. Association between bone turnover, micronutrient intake, and blood lead levels in pre- and postmenopausal women, NHANES 1999-2002. Environ. Health Perspect. 2010, 118:1590-1596.
13. Jedrychowski W., et al. Gender specific differences in neurodevelopmental effects of prenatal exposure to very low-lead levels: the prospective cohort study in three-year olds. Early Hum. Dev. 2009, 85:503-510.
14. Kang J.H., et al. Apolipoprotein E, cardiovascular disease and cognitive function in aging women. Neurobiol. Aging 2005, 26:475-484.
15. Khalil N., et al. Association of cumulative lead and neurocognitive function in an occupational cohort. Neuropsychology 2009, 23:10-19.
16. Kim R., et al. K x-ray fluorescence measurements of bone lead concentration: the analysis of low-level data. Phys. Med. Biol. 1995, 40:1475-1485.
17. Korrick S.A., et al. Lead and hypertension in a sample of middle-aged women. Am. J. Public Health 1999, 89:330-335.
18. Korrick S.A., et al. Correlates of bone and blood lead levels among middle-aged and elderly women. Am. J. Epidemiol. 2002, 156:335-343.
19. Lasley S.M., Gilbert M.E. Glutamatergic components underlying lead-induced impairments in hippocampal synaptic plasticity. Neurotoxicology 2000, 21:1057-1068.
20. Lee S., et al. Education, other socioeconomic indicators, and cognitive function. Am. J. Epidemiol. 2003, 157(8):712-720.
21. Machida M., et al. High bone matrix turnover predicts blood levels of lead among perimenopausal women. Environ. Res. 2009, 109:880-886.
22. Manolio T.A., et al. Hypertension and cognitive function: pathophysiologic effects of hypertension on the brain. Curr. Hypertens. Rep. 2003, 5:255-261.
23. McNeill F.E., et al. Factors affecting in vivo measurement precision and accuracy of 109Cd K x-ray fluorescence measurements. Phys. Med. Biol. 1999, 44:2263-2273.
24. Monteiro I.M., et al. Reliability of routine clinical instruments for the assessment of Alzheimer's disease administered by telephone. J. Geriatr. Psychiatry Neurol. 1998, 11(1):18-24.
25. Muldoon S.B., et al. Effects of blood lead levels on cognitive function of older women. Neuroepidemiology 1996, 15:62-72.
26. Muntner P., et al. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch. Intern. Med. 2005, 165:2155-2161.
27. Navas-Acien A., et al. Lead exposure and cardiovascular disease-a systematic review. Environ. Health Perspect. 2007, 115:472-482.
28. Nie H., et al. Application and methodology of in vivo K x-ray fluorescence of Pb in bone (impact of KXRF data in the epidemiology of lead toxicity, and consistency of the data generated by updated systems). X-Ray Spectrom. 2008, 37:69-75.
29. Qiu C., et al. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005, 4:487-499.
30. Rankin M., et al. Correlation analysis of the in-clinic and telephone batteries from the AREDS Cognitive Function Ancillary Study. AREDS report no. 15. Ophthalmic Epidemiol. 2005, 12(4):271-277.
31. Rapp S.R., et al. Validation of a cognitive assessment battery administered over the telephone. J. Am. Geriatr. Soc. 2012, 60(9):1616-1623.
32. Richardson D.B., et al. Analyses of case-control data for additional outcomes. Epidemiology 2007, 18:441-445.
33. Schneider J.S., et al. Sex-based differences in gene expression in hippocampus following postnatal lead exposure. Toxicol. Appl. Pharmacol. 2011, 256:179-190.
34. Schulz R., Beach S.R. Caregiving as a risk factor for mortality: the Caregiver Health Effects Study. J. Am. Med. Assoc. 1999, 282:2215-2219.
35. Schwartz B.S., et al. Occupational lead exposure and longitudinal decline in neurobehavioral test scores. Epidemiology 2005, 16:106-113.
36. Schwartz B.S., et al. Past adult lead exposure is associated with longitudinal decline in cognitive function. Neurology 2000, 55:1144-1150.
37. Seeman E. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporos. Int. 2003, 14(Suppl. 3):S2-S8.
38. Shaw W.S., et al. Longitudinal analysis of multiple indicators of health decline among spousal caregivers. Ann. Behav. Med. 1997, 19:101-109.
39. Shih R.A., et al. Environmental lead exposure and cognitive function in community-dwelling older adults. Neurology 2006, 67:1556-1562.
40. Shih R.A., et al. Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Environ. Health Perspect. 2007, 115:483-492.
41. Tabert M.H., et al. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch. Gen. Psychiatry 2006, 63:916-924.
42. Unverzagt F.W., et al. The Indiana University telephone-based assessment of neuropsychological status: a new method for large scale neuropsychological assessment. J. Int. Neuropsychol. Soc. 2007, 13(05):799-806.
43. van Wijngaarden E., et al. Bone lead levels are associated with measures of memory impairment in older adults. Neurotoxicology 2009, 30:572-580.
44. van Wijngaarden E., et al. Blood lead levels in relation to cognitive function in older U.S. adults. Neurotoxicology 2011, 32:110-115.
45. Ware J., et al. SF-36 Health Survey: Manual Interpretation and Guide 1993, Nimrod Press, Boston, MA.
46. Weisskopf M.G., et al. Cumulative lead exposure and cognitive performance among elderly men. Epidemiology 2007, 18:59-66.
47. Weisskopf M.G., et al. Cumulative lead exposure and prospective change in cognition among elderly men: the VA Normative Aging Study. Am. J. Epidemiol. 2004, 160:1184-1193.
48. Weuve J., et al. Cumulative exposure to lead in relation to cognitive function in older women. Environ. Health Perspect. 2009, 117:574-580.
49. Wilker E., et al. Longitudinal changes in bone lead levels: the VA Normative Aging Study. J. Occup. Environ. Med. 2011, 53:850-855.
50. Wright R.O., et al. Lead exposure biomarkers and mini-mental status exam scores in older men. Epidemiology 2003, 14:713-718.